Transactions

Peterson Law represents Revive Therapeutics Ltd. as it closes $3,000,000 Public Offering of units

On December 18, 2014, Revive Therapeutics Ltd. (“Revive”) closed a public offering of 4,996,500 units (“Units”) at a price of $0.60 per Unit for gross proceeds of $2,997,900. Each Unit was comprised of one common share and one warrant entitling the holder thereof to purchase one additional common share for $0.85 for a period of two years from the date of issuance, subject to acceleration under certain circumstances.

Revive’s public offering was led by Beacon Securities Limited (“Beacon”) as the sole agent and bookrunner. Beacon was paid a cash commission and 349,755 compensation options, each such option entitling the holder to purchase one Unit for $0.60 for a period of two years from the date of issuance.

Back

Recent Transactions

31 May 2022

Peterson McVicar Acts for Red Cloud Securities Inc. in Brokered Private Placement with Reyna Silver Corp. for up to C$3.0 Million

Learn More

30 May 2022

Peterson McVicar Acts for Probe Metals in Private Placement

Learn More

06 May 2022

Peterson McVicar Acts for Galway Metals in Upsizing of $8 Million Bought Deal Private Placement Financing to $10 Million

Learn More

05 May 2022

Peterson McVicar Acts for Galway Metals in $8 Million Bought Deal Private Placement Financing

Learn More